Zurig Tablets (Febuxostat) | Treats Hyperuricemia and Chronic Gout Attacks
Zurig Tablet contains Febuxostat, a xanthine oxidase inhibitor used to treat chronic hyperuricaemia (high uric acid levels) in adults with gout. Helps lower and maintain uric acid levels in the blood, reducing the frequency of gout attacks and preventing urate crystal deposits in the joints and kidneys. FEBUXOSTAT belongs to a class of anti-gout medications, also known as xanthine oxidase inhibitors, which are widely used to prevent severe gout attacks or flare-ups.
Product Overview
Zurig Tablet is a potent, non-purine xanthine oxidase inhibitor (XOI) developed for the chronic management of hyperuricemia in patients with gout. Featuring the active ingredient Febuxostat, Zurig provides a highly selective method for reducing elevated levels of uric acid in the bloodstream. Unlike traditional treatments, its unique chemical structure allows it to inhibit both the oxidized and reduced forms of the xanthine oxidase enzyme, leading to more consistent and effective control of serum urate. This medication is particularly valuable for achieving target uric acid levels in patients who have shown an inadequate response to other urate-lowering therapies.
Product Composition
- Active Ingredient: Febuxostat
- Strengths: Available in 40mg and 80mg film-coated tablets
- Drug Class: Antigout / Selective Xanthine Oxidase Inhibitor
- Excipients: Includes Lactose Monohydrate and Microcrystalline Cellulose
Product Specification
| Feature | Details |
| Therapeutic Class | Hypouricemic Agent |
| Mechanism | Non-competitive inhibition of Xanthine Oxidase |
| Metabolism | Hepatic (Liver) metabolism via glucuronidation |
| Half-Life | Approximately 5 to 8 hours |
| Dosing Frequency | Once-daily oral administration |
Mechanism of Action
- Enzymatic Blockade: Zurig targets the enzyme xanthine oxidase, which is responsible for the final two steps of purine metabolism: converting hypoxanthine to xanthine, and xanthine to uric acid.
- Selective Potency: As a non-purine analog, it binds specifically to the molybdenum-pterin center of the enzyme, ensuring it does not interfere with other enzymes involved in purine or pyrimidine synthesis.
- Serum Urate Reduction: By halting the production of uric acid, the medication lowers the concentration of serum urate, creating a concentration gradient that encourages existing urate crystals to leave the joints.
- Crystal Dissolution: Continuous use maintains blood levels below the saturation point ($< 6.0 \text{ mg/dL}$), which prevents the precipitation of new monosodium urate crystals and facilitates the gradual dissolution of existing deposits.
Key Benefits
- Rapid Urate Lowering: Demonstrated efficacy in significantly reducing serum uric acid levels within the first two weeks of therapy.
- Target Level Achievement: Helps a high percentage of patients reach clinical targets necessary to stop gout flare-ups.
- Renal Safety Profile: Can be used in patients with mild-to-moderate renal impairment without the need for significant dose adjustments compared to purine-based alternatives.
- Prevention of Tophi: Effective in reducing the size and presence of tophi (calcified uric acid bumps), leading to improved joint mobility.
- Consistent Control: The once-daily dosing regimen provides 24-hour metabolic management, stabilizing the internal environment against sudden uric acid spikes.
Usage
To ensure the long-term success of Zurig Tablet therapy, it must be taken consistently as a preventative measure. This medication is not designed to treat the immediate pain of an acute gout attack; rather, it works to stabilize the body's chemistry over time. Patients starting Febuxostat therapy are often prescribed a secondary anti-inflammatory (such as an NSAID or colchicine) for the first few months to manage any temporary increase in flares that can occur as urate crystals begin to mobilize.
Dosage and Administration
Standard Regimen: The typical starting dose is 40mg once daily. If serum uric acid levels do not drop below 6 mg/dL after two weeks, the dose may be increased to 80mg.
Consistency: Take the tablet at the same time every day to maintain a steady level of enzyme inhibition.
Administration: The tablet should be swallowed whole with water. It can be taken with or without food, as dietary intake does not significantly alter the bioavailability of the drug.
Hydration: Maintaining high fluid intake is recommended to assist the body in the efficient elimination of metabolic waste.
Missed Dose: If a dose is missed, take it as soon as possible. If it is nearly time for the next dose, skip the missed one. Do not take two doses at once.
Treatment Continuity: Do not stop taking Zurig even if you have a gout flare-up. Continue the medication and consult a healthcare provider for separate pain management for the flare.
Uses
Zurig Tablet is a specialized hypouricemic agent indicated for the management of conditions caused by an overabundance of uric acid in the body. By regulating the metabolic production of urate, it addresses the root cause of crystal-induced inflammation.
Clinical Applications
| Category | Specific Application |
| Chronic Hyperuricemia | Long-term lowering of high blood uric acid levels in patients with chronic gout. |
| Gout Prophylaxis | Prevention of recurrent gouty arthritis attacks and joint swelling. |
| Tophaceous Gout | Treatment aimed at dissolving tophi (urate deposits) in joints, tendons, and soft tissues. |
| Joint Preservation | Preventing the erosive joint damage and permanent deformity associated with long-term urate accumulation. |
Targeted Action Areas
Xanthine Oxidase Inhibition: Directly blocks the primary catalyst for uric acid production, reducing the systemic burden of urate.
Metabolic Balancing: Helps restore the balance between the production and excretion of purine metabolites, preventing tissue saturation.
Crystalline Mobilization: Lowers blood urate levels enough to trigger the re-absorption of monosodium urate crystals from the joints back into the bloodstream for excretion.
Flare Frequency Reduction: By maintaining a stable, low-urate environment, it significantly decreases the likelihood of the sudden inflammatory responses that cause acute pain.
Side Effects
Common Side Effects
Zurig Tablets may cause mild side effects in some individuals, particularly during the initial phase of treatment.
- Nausea
- Headache
- Joint pain
- Skin rash
- Diarrhea
- Dizziness
- Mild swelling
- Increased liver enzyme levels
Serious Side Effects
| Serious Side Effect | Symptoms |
|---|---|
| Severe allergic reaction | Swelling, breathing difficulty, severe rash |
| Liver problems | Yellowing of skin or eyes, dark urine, fatigue |
| Heart related complications | Chest pain, shortness of breath, irregular heartbeat |
| Severe skin reactions | Blistering, peeling, widespread rash |
| Persistent gout flare-ups | Severe joint swelling, redness, intense pain |
Gout Flare Effects
Febuxostat may initially trigger gout attacks as uric acid levels begin to decrease in the body.
Digestive System Effects
Some individuals may experience nausea, diarrhea, or stomach discomfort during treatment.
Liver Related Effects
Long-term therapy may affect liver enzyme levels, so periodic monitoring may be advised.
Skin and Allergy Effects
Mild rash or itching may occur, while severe allergic skin reactions are rare but require immediate attention.
Heart Health Effects
Patients with existing heart disease should monitor for chest discomfort, breathing problems, or unusual heartbeat changes.
When to Seek Medical Help
Stop use and seek immediate medical attention if you experience severe rash, breathing difficulty, chest pain, yellowing of eyes or skin, or signs of serious allergic reaction.
FAQs
Q: What is Zurig Tablet used for?
A: It is used to treat chronic hyperuricaemia (high uric acid levels) in adults with gout. It helps lower and maintain uric acid levels in the blood, reducing the frequency of gout attacks and preventing urate crystal deposits in the joints and kidneys.
Q: What is the active ingredient in Zurig Tablet?
A: The active ingredient is febuxostat, which belongs to the xanthine oxidase inhibitor class of medicines.
Q: How does Zurig Tablet work?
A: It works by blocking xanthine oxidase, an enzyme involved in the production of uric acid in the body. By inhibiting this enzyme, it reduces the amount of uric acid produced and lowers uric acid levels in the blood.
Q: Is Zurig Tablet a prescription medicine?
A: Yes. It is a prescription-only medicine and should be used strictly under the supervision of a doctor.
Q: How should I take Zurig Tablet?
A: Take it once daily with or without food. Swallow the tablet whole with a full glass of water at the same time each day.
Q: What is the usual dose of Zurig Tablet?
A: The usual starting dose is 80 mg once daily. Your doctor may increase the dose to 120 mg once daily if uric acid levels remain high after several weeks of treatment.
Q: How long does it take to lower uric acid levels?
A: Uric acid levels usually begin to fall within a few days of starting treatment. However it may take several weeks to months to reach and maintain the target uric acid level.
Q: Can Zurig Tablet cause gout flares when I first start taking it?
A: Yes. Gout flares may occur more frequently during the first few months of treatment as uric acid crystals begin to dissolve and move. Your doctor may prescribe a preventive anti-inflammatory medicine such as colchicine or an NSAID alongside Zurig to manage this.
Q: What if I miss a dose?
A: Take it as soon as you remember. If it is nearly time for the next dose, skip the missed one — never double up.
Q: Can I stop taking Zurig Tablet once my gout improves?
A: No. Zurig is a long-term treatment. Stopping it can cause uric acid levels to rise again and gout attacks to return. Always consult your doctor before making any changes to your treatment.
Q: What are the most common side effects?
A: Nausea, diarrhoea, headache, joint pain, rash, and abnormal liver function test results.
Q: Are there any serious side effects?
A: Yes — serious side effects can include severe allergic reactions, liver problems, and cardiovascular events such as heart attack and stroke. Seek immediate medical attention if you experience chest pain, signs of liver problems such as yellowing of the skin or eyes, or severe skin reactions.
Q: Is Zurig Tablet safe for patients with heart disease?
A: Use with caution in patients with established cardiovascular disease. Studies have shown a possible increased risk of cardiovascular events with febuxostat compared to allopurinol in patients with existing heart conditions. Discuss the risks and benefits with your doctor.
Q: Is it safe for patients with kidney problems?
A: Zurig can be used in patients with mild to moderate kidney impairment without dose adjustment. However caution is advised in severe kidney impairment. Always inform your doctor about your kidney condition.
Interactions
| General Interaction | Details |
|---|---|
| Azathioprine | Increased risk of serious toxicity |
| Mercaptopurine | May increase medicine levels and side effects |
| Theophylline | Higher risk of theophylline-related side effects |
| Other gout medicines | Combination may require monitoring or dose adjustment |
| Antacids | May slightly reduce absorption if taken together |
| Alcohol | May worsen gout symptoms and increase uric acid levels |
Interaction with Immunosuppressant Medicines
Zurig Tablets should generally not be combined with azathioprine or mercaptopurine because it may lead to serious toxicity.
Interaction with Respiratory Medicines
Febuxostat may increase the effects of theophylline and raise the risk of side effects.
Interaction with Other Gout Treatments
Using multiple uric acid lowering medicines together may require dose adjustments and careful monitoring to maintain safe uric acid levels.
Interaction with Antacids
Antacids taken too close to Zurig Tablets may slightly reduce medicine absorption, so maintaining a time gap may help improve effectiveness.
Interaction with Alcohol
Alcohol may increase uric acid levels and trigger gout flare-ups, reducing treatment effectiveness.
Dietary Interaction Considerations
Foods rich in purines such as red meat, organ meat, seafood, and sugary beverages may worsen gout symptoms and affect treatment response.
General Safety Advice
Always inform your healthcare provider about all medicines, supplements, and herbal products being used before or during treatment with Zurig Tablets.
| Manufacturer | : | Zydus Cadila |
| Trade Name | : | Uloric |
| Generic Search | : | Febuxostat |
| Strength | : | 40mg, 80mg |
Latest Products
